<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <originChamber>House</originChamber>
    <recordedVotes />
    <congress>114</congress>
    <title>Empowering Pharmacists in the Fight Against Opioid Abuse Act</title>
    <latestAction>
      <text>Referred to the House Committee on Energy and Commerce.</text>
      <links />
      <actionDate>2016-05-24</actionDate>
    </latestAction>
    <notes />
    <updateDate>2018-11-21T21:23:36Z</updateDate>
    <amendments />
    <committees>
      <billCommittees>
        <item>
          <systemCode>hsif00</systemCode>
          <subcommittees />
          <chamber>House</chamber>
          <activities>
            <item>
              <date>2016-05-24T14:01:30Z</date>
              <name>Referred to</name>
            </item>
          </activities>
          <name>Energy and Commerce Committee</name>
          <type>Standing</type>
        </item>
      </billCommittees>
    </committees>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 162, Number 82 (Tuesday, May 24, 2016)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. DeSAULNIER:H.R. 5314.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 3[Page H3094]</pre>]]></constitutionalAuthorityStatementText>
    <relatedBills />
    <summaries>
      <billSummaries>
        <item>
          <lastSummaryUpdateDate>2016-07-20T19:00:26Z</lastSummaryUpdateDate>
          <actionDesc>Introduced in House</actionDesc>
          <versionCode>00</versionCode>
          <name>Introduced in House</name>
          <updateDate>2016-05-24T04:00:00Z</updateDate>
          <text><![CDATA[<p><b>Empowering Pharmacists in the Fight Against Opioid Abuse Act</b></p> <p>This bill requires the Drug Enforcement Administration (DEA) to develop and disseminate training programs and materials on: (1) the circumstances under which a pharmacist may refuse to fill a controlled substance prescription suspected to be fraudulent, forged, or indicative of abuse or diversion; and (2) federal requirements related to such refusal.</p> <p>The DEA must seek input from relevant stakeholders.</p>]]></text>
          <actionDate>2016-05-24</actionDate>
        </item>
      </billSummaries>
    </summaries>
    <createDate>2016-05-25T05:16:53Z</createDate>
    <billNumber>5314</billNumber>
    <billType>HR</billType>
    <cosponsors>
      <item>
        <bioguideId>C001103</bioguideId>
        <identifiers>
          <bioguideId>C001103</bioguideId>
          <gpoId />
          <lisID>2236</lisID>
        </identifiers>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <firstName>Earl</firstName>
        <middleName>L. "Buddy"</middleName>
        <sponsorshipDate>2016-05-24</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <state>GA</state>
        <lastName>Carter</lastName>
        <fullName>Rep. Carter, Earl L. "Buddy" [R-GA-1]</fullName>
        <party>R</party>
        <district>1</district>
      </item>
    </cosponsors>
    <version>1.0.0</version>
    <actions>
      <actionTypeCounts>
        <billReferrals>1</billReferrals>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
      <actionByCounts>
        <houseOfRepresentatives>3</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionDate>2016-05-24</actionDate>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <links />
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2016-05-24</actionDate>
        <committee />
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <links />
        <text>Introduced in House</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2016-05-24</actionDate>
        <committee />
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <links />
        <text>Introduced in House</text>
        <type>IntroReferral</type>
      </item>
    </actions>
    <laws />
    <titles>
      <item>
        <chamberName />
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
        <title>Empowering Pharmacists in the Fight Against Opioid Abuse Act</title>
        <chamberCode />
      </item>
      <item>
        <chamberName />
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <title>To provide for the development and dissemination of programs and materials for training pharmacists, health care providers, and patients on the circumstances under which a pharmacist may decline to fill a prescription for a controlled substance because the pharmacist suspects the prescription is fraudulent, forged, or otherwise indicative of abuse or diversion, and for other purposes.</title>
        <chamberCode />
      </item>
      <item>
        <chamberName />
        <titleType>Display Title</titleType>
        <parentTitleType />
        <title>Empowering Pharmacists in the Fight Against Opioid Abuse Act</title>
        <chamberCode />
      </item>
    </titles>
    <cboCostEstimates />
    <sponsors>
      <item>
        <byRequestType />
        <lastName>DeSaulnier</lastName>
        <middleName />
        <state>CA</state>
        <identifiers>
          <lisID>2227</lisID>
          <bioguideId>D000623</bioguideId>
          <gpoId />
        </identifiers>
        <bioguideId>D000623</bioguideId>
        <fullName>Rep. DeSaulnier, Mark [D-CA-11]</fullName>
        <firstName>Mark</firstName>
        <district>11</district>
        <party>D</party>
      </item>
    </sponsors>
    <committeeReports />
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Crime and Law Enforcement</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Drug trafficking and controlled substances</name>
          </item>
          <item>
            <name>Fraud offenses and financial crimes</name>
          </item>
          <item>
            <name>Government information and archives</name>
          </item>
          <item>
            <name>Health personnel</name>
          </item>
          <item>
            <name>Health promotion and preventive care</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <introducedDate>2016-05-24</introducedDate>
    <calendarNumbers />
    <policyArea>
      <name>Crime and Law Enforcement</name>
    </policyArea>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

